Published: 2017-01-16

Quality of life among Ardabil patients with beta-thalassemia major

Firouz Amani, Afshin Fathi, Mehdi Valizadeh, Esmaeil Farzaneh, Ghasem Fattahzadeh-Ardalani


Background: Thalassemia as the most common genetic disorder worldwide is regarded as a serious problem in public health issues in the Mediterranean region. Patients with beta-thalassemia major experience physical, psychological and social problems that lead to decreased quality of life. The aim of this study was to assess health-related quality of life and its determinants among patients with major beta-thalassemia.

Methods: This was a population-based cross-sectional survey of quality of life. Population with thalassemia major (aged ≥ 2 years) of both genders who had records in Thalassemia Clinic of Bu-Ali Hospital, and those who regularly refer for blood transfusion or follow-up visits. Data were collected from December 2013 to May 2014.The self-administered short form-36 (SF-36) questionnaire was used to measure quality of life in patients with thalassemia. Data were analysed using descriptive statistical tests (mean, SD, and frequency), and inferential statistical test (t-test) in SPSS.17 software.

Results: Our samples were 20 men and 23 women. The median age was 20 years (2-42). After reviewing the patients' quality of life, it was observed that the mean score for physical function was 79.8, role limitations due to physical reasons 78.8, bodily pain 74.4, general health 59.1, fatigue or vitality 63.3, social function 70.21, role limitations due to psychological reasons (emotional) 77.3 and mental health 65.4. On two scales, role physical (P = 0.33) and role emotional (P = 0.13), the men showed significantly lower scores than the women.

Conclusions: After reviewing the patients' quality of life, the highest quality in physical function and lowest quality in general health of patients were observed. In the quality of care data all scales were in very good level except general health.



Iran, Thalassemia major, Quality of life, Short form-36

Full Text:



Thavorncharoensap M, Torcharus K, Nuchprayoon I, Riewpaiboon A, Indaratna K, Ubol B. Factors affecting health-related quality of life in Thai children with thalassemia. BMC Blood Disorders. 2010;10:1.

Weatherall D. 2003 William Allan Award address. The Thalassemias: the role of molecular genetics in an evolving global health problem. Am J Hum Genet. 2004;74(3):385-92.

Khamoushi F, Ahmadi SM, Karami-Matin B, Ahmadi-Jouybari T. Prevalence and Socio-Demographic Characteristics Related to Stress, Anxiety, and Depression among Patients with Major Thalassemia in the Kermanshah County. J Biol Todey's World. 2015;4(3):79-84.

Roudbari M, Soltani-Rad M, Roudbari S. The survival analysis of beta thalassemia major patients in South East of Iran. Saudi Med J. 2008;29:1031-5.

Dahui M, Hishamshan MI, Rahman AJA, Aljuid SM. Quality of life in transfusion- dependent thalassaemia patients on desferrioxamine treatment. Singapore medj. 2009;50:794-9.

Levine L, Levine M. Health care transition in thalassemia: pediatric to adult-oriented care. Ann N Y Acad Sci. 2010;1202:244-7.

Pakbaz Z, Treadwell M, Yamashita R, Quirolo K, Foote D, Quill L, et al. Quality of life in patients with thalassemia intermedia compared to thalassemia major. Ann NY Acad Sci. 2005;1054:457-61.

Telfer P, Coustantinidou G, Andreou P, Christou S, Modell B, Angastiniotis M. Quality of life in thalassemia. Ann NY Acad Sci. 2005;1054:273-82.

Olivieri NF. The beta-thalassemias. New England Journal of Medicine. 1999;341:99-109.

Jarman F, Oberklaid F. Children with chronic illness: Factors affecting psychosocial adjustment. Current Opinion in Pediatrics. 1990;2(3):868-72.

Safizadeh H, Farahmandinia Z, Soltaninejad S, Pourdamghan N, Araste M. Quality of life in patients with thalassemia major and intermedia in Kerman-Iran. Mediterr J Hematol Infect Dis. 2012;4:e2012058.

Azarkeivan A, Hajibeigi B, Alavian SM, Lankarani MM, Assari S. Associates of poor physical and mental health-related quality of life in beta-thalassemia major/intermedia. J Res Med Sci. 2009;14:349-55.

Hadi N, Karami D, Montazeri A. Health-related quality of life in major thalassemic patients. Payesh. 2009;8:387-93.

Ismail A, Campbell MJ, Ibrahim HM, Jones GL. Health related quality of life in Malaysian children with thalassemia. Health Qual Life Outcomes. 2006;4:39.

Caocci G, Efficace F, Ciotti F, Roncarolo MG, Vacca A, Piras E, et al. Health related quality of life in Middle Eastern children with beta-thalassemia. BMC Blood Disord. 2012;12:6.

Balkhoyor AH, Abulaban AA, Azab AM, Radi SA, Ayoub MD, et al. Quality of life among adults with beta-thalassemia major in western Saudi Arabia. Saudi medical journal. 2014;35(8):882-5.

Khani H, Majdi MR, Montazeri A, Hosseini SH, Ghorbani A, Ramezani M, et al. Quality of life in Iranian Beta-thalassemia major patients of southern coastwise of the Caspian Sea. Journal of Behavioral Sciences. 2007;8(35-36):325-32.

Haghpanah S, Nasirabadi Sh, Ghaffarpasand F, Karami R. Quality of life among Iranian patients with beta-thalassemia major using the SF-36 questionnaire. Sao Paulo Med J. 2013;131(3):166-72.

Gollo G, Savioli G, Balocco M, Venturino C, Boeri E, Costantini M, et al. Changes in the quality of life of people with thalassemia major between 2001 and 2009. Patient Preference and Adherence. 2013:7.

Tajvar M, Arab M, Montazeri A. Determinants of health-related quality of life in elderly in Tehran, Iran. BMC Public Health. 2008;8:323.

Sobota A, Yamashita R, Xu Y. Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms. Am J Hematol. 2011;86(1):92-5.